Current trends and perspectives on bioaccessibility and bioavailability of food bioactive peptides: in vitro and ex vivo studies

被引:7
|
作者
Alvarez-Olguin, Miguel A. [1 ]
Beltran-Barrientos, Lilia M. [1 ]
Hernandez-Mendoza, Adrian [1 ]
Gonzalez-Cordova, Aaron F. [1 ]
Vallejo-Cordoba, Belinda [1 ]
机构
[1] Ctr Invest Alimentac & Desarrollo, Coordinac Tecnol Alimentos Origen Anim, Hermosillo, Sonora, Mexico
关键词
simulated gastrointestinal digestion; bioaccessibility; bioactive peptides; bioactivity; SIMULATED GASTROINTESTINAL DIGESTION; ILE-PRO-PRO; ACE-INHIBITORY PEPTIDES; TRANSEPITHELIAL TRANSPORT; INTESTINAL-ABSORPTION; ANTIHYPERTENSIVE PEPTIDES; MILK; CACO-2; MODEL; IDENTIFICATION;
D O I
10.1002/jsfa.12077
中图分类号
S [农业科学];
学科分类号
09 ;
摘要
The bioaccessibility and bioavailability of food-derived bioactive compounds are important issues when assessing their in vivo physiological health-promoting effects. Food components such as proteins and peptides are exposed to different proteases and peptidases during gastrointestinal digestion and absorption. Different in vitro approaches have therefore been developed to evaluate the bioaccessibility and stability of bioactive peptides. The static simulated gastrointestinal digestion model (SGD) was widely reported to assess the bioaccessibility of bioactive peptides. On the other hand, although the dynamic SGD model may better simulate human digestion, it has rarely been explored in bioaccessibility studies of food bioactive peptides due to its high cost and lack of standardization. For bioavailability studies, the Caco-2 cell monolayer model has been used extensively for the assessment of food bioactive peptides. In fact, very few reports using alternative methods for determining transepithelial transport of bioactive peptides have been employed. In this sense, ex vivo tissue-based models such as the Ussing chamber and the everted sac gut have been used. Current evidence supports the fact that using SGD with cell-based models for evaluating the bioaccessibility, absorption, and bioavailability of food-derived bioactive peptides, is the most commonly used approach. Nevertheless, SGD with ex vivo tissue-based models such as the everted sac, remains to be further explored because it seems to be the model that better mimics the physiological process - it is also fast and inexpensive, and several compounds may be tested simultaneously. In the present review, we discuss information available on the different in vitro approaches for the determination of bioaccessibility and bioavailability of food-derived bioactive peptides with special emphasis on ex vivo tissue-based models such as the everted sac and the Ussing chamber models. (c) 2022 Society of Chemical Industry.
引用
收藏
页码:6824 / 6834
页数:11
相关论文
共 50 条
  • [1] Current understanding of bioaccessibility and bioavailability of food-derived bioactive peptides
    Mine, Yoshinori
    Matsui, Toshiro
    [J]. INTERNATIONAL JOURNAL OF FOOD SCIENCE AND TECHNOLOGY, 2019, 54 (07): : 2319 - 2320
  • [2] Current trends and perspectives of bioactive peptides
    Daliri, Eric Banan-Mwine
    Lee, Byong H.
    Oh, Deog H.
    [J]. CRITICAL REVIEWS IN FOOD SCIENCE AND NUTRITION, 2018, 58 (13) : 2273 - 2284
  • [3] Current Evidence on the Bioavailability of Food Bioactive Peptides
    Amigo, Lourdes
    Hernandez-Ledesma, Blanca
    [J]. MOLECULES, 2020, 25 (19):
  • [4] Bioaccessibility of bioactive peptides: recent advances and perspectives
    Udenigwe, Chibuike C.
    Abioye, Raliat O.
    Okagu, Innocent U.
    Obeme-Nmom, Joy, I
    [J]. CURRENT OPINION IN FOOD SCIENCE, 2021, 39 : 182 - 189
  • [5] Loading bioactive peptides within different nanocarriers to enhance their functionality and bioavailability; in vitro and in vivo studies
    Department of Nutritional Sciences, School of Health, Mazandaran University of Medical Sciences, Sari, Iran
    不详
    不详
    不详
    34469, Turkey
    不详
    不详
    不详
    不详
    不详
    不详
    [J]. Adv Colloid Interface Sci,
  • [6] Bioaccessibility and bioavailability of biofortified food and food products: Current evidence
    Huey, Samantha L.
    Mehta, Neel H.
    Konieczynski, Elsa M.
    Bhargava, Arini
    Friesen, Valerie M.
    Krisher, Jesse T.
    Mbuya, Mduduzi N. N.
    Monterrosa, Eva
    Nyangaresi, Annette M.
    Boy, Erick
    Mehta, Saurabh
    [J]. CRITICAL REVIEWS IN FOOD SCIENCE AND NUTRITION, 2024, 64 (14) : 4500 - 4522
  • [7] In Vitro and In Vivo Evaluating Bioaccessibility, Bioavailability, and Antioxidant Activities of Butterfly Pea Flower Containing Bioactive Constitutes
    Yu, Fengyao
    Yu, Qinqin
    Yin, Ning
    Sun, Genlin
    Peng, You
    Zeng, Yan
    Sun, Yong
    Wang, Xiaoya
    Zhang, Hua
    [J]. FOODS, 2024, 13 (10)
  • [8] Metabolic profiling, in vitro bioaccessibility and in vivo bioavailability of a commercial bioactive Epilobium angustifolium L. extract
    Dacrema, Marco
    Sommella, Eduardo
    Santarcangelo, Cristina
    Bruno, Beatrice
    Marano, Maria Grazia
    Insolia, Violetta
    Saviano, Anella
    Campiglia, Pietro
    Stornaiuolo, Mariano
    Daglia, Maria
    [J]. BIOMEDICINE & PHARMACOTHERAPY, 2020, 131
  • [9] Bioavailability and bioaccessibility of food bioactive compounds; overview and assessment byin vitromethods
    Dima, Cristian
    Assadpour, Elham
    Dima, Stefan
    Jafari, Seid Mahdi
    [J]. COMPREHENSIVE REVIEWS IN FOOD SCIENCE AND FOOD SAFETY, 2020, 19 (06): : 2862 - 2884
  • [10] Study on the bioaccessibility and bioavailability of Cd in contaminated rice in vitro and in vivo
    Yao, Liyun
    Wang, Yixin
    Deng, Ziyi
    Wu, Qian
    Fang, Min
    Wu, Yongning
    Gong, Zhiyong
    [J]. JOURNAL OF FOOD SCIENCE, 2021, 86 (08) : 3730 - 3742